Autopsy report · NCT02893982
High Dose Rate Brachyablation of Primary Liver Lesions
Cause of deathSlow enrollment
“Study was closed due to poor accrual”
Life of this trial
- Registered 1 year 2 months before it started.
- Ran for about 2 years 4 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Liver Cancer
- Interventions
- brachytherapy
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
“Study was closed to low accrual.” - S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
“This study was closed early due to poor accrual” - Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
“Study was halted for lack of accrual” - Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
“accrual was slow and sporadic so the study was closed” - Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
“Study stopped due to lack of accrual”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.